Differential effects of HTLV-1 Tax oncoprotein on the different estrogen-induced-ER α-mediated transcriptional activities

References

• Hockings JK, Degner SC, Morgan SS, Kemp MQ, Romagnolo DF. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Breast Cancer Res 2008; 10(2):R29; PMID:18377656; http://dx.doi.org/10.1186/bcr1987
   PubMedGoogle Scholar
• Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 2005; 19:1951-9; PMID:15705661; http://dx.doi.org/10.1210/me.2004-0390
   PubMed Web of Science ®Google Scholar
• Girault I, Bieche I, Lidereau R. Role of estrogen receptor α transcriptional coregulators in tamoxifen resistance in breast cancer. Maturitas 2006; 54:342-51; PMID:16822624; http://dx.doi.org/10.1016/j.maturitas.2006.06.003
   PubMed Web of Science ®Google Scholar
• Kushner PJ, Agard D, Feng WJ, Lopez G, Schiau A, Uht R, Webb P, Greene G. Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp 2000; 230:20-6; PMID:10965500; http://dx.doi.org/10.1002/0470870818.ch3
   PubMedGoogle Scholar
• Jeffy BD, Hockings JK, Kemp MQ, Morgan SS, Hager JA, Beliakoff J, Whitesell LJ, Bowden GT, Romagnolo DF. An estrogen receptor-a/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription. Neoplasia 2005; 7:873-82; PMID:16229810; http://dx.doi.org/10.1593/neo.05256
   PubMed Web of Science ®Google Scholar
• Jeffy BD, Hockings JK, Kemp MQ, Morgan SS, Hager JA, Beliakoff J, Whitesell LJ, Bowden GT, Romagnolo DF. An estrogen receptor-a/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription. Neoplasia 2005; 7:873-82; PMID:16229810; http://dx.doi.org/10.1593/neo.05256
   PubMed Web of Science ®Google Scholar
• Marks JR, Huper G, Vaughn JP, Davis PL, Norris J, McDonnell DP, Wiseman RW, Futreal PA, Iglehart JD. BRCA1 expression is not directly responsive to estrogen. Oncogene 1997; 14:115-21; PMID:9010238; http://dx.doi.org/10.1038/sj.onc.1200808
   PubMed Web of Science ®Google Scholar
• Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997 Sep 5; 277(5331):1508-10; PMID:9278514; http://dx.doi.org/10.1126/science.277.5331.1508
   PubMed Web of Science ®Google Scholar
• Merchant JS, Oh K, Klerman LV. Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochem Biophys Res Commun 1999 Jan 19; 254(2):454-61; PMID:9918860; http://dx.doi.org/10.1006/bbrc.1998.9964
   PubMed Web of Science ®Google Scholar
• Hockings JK, Thorne PA, Kemp MQ, Morgan SS, Selmin O, Romagnolo DF. The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen. Cancer Res 2006; 66:2224-32; PMID:16489025; http://dx.doi.org/10.1158/0008-5472.CAN-05-1619
   PubMed Web of Science ®Google Scholar
• Wang W, Schneider-Broussard R, Kumar A, MacLeod M, Johnson D. Regulation of BRCA1 Expression by the Rb-E2F Pathway. J Biol Chem 2000; 275:4532-6; http://dx.doi.org/10.1074/jbc.275.6.4532
   PubMed Web of Science ®Google Scholar
• Wang A, Schneider-Broussard R, Kumar AP, MacLeod MC, Johnson DG. Regulation of BRCA1 expression by the Rb-E2F pathway. J Biol Chem 2000; 275:4532-6; PMID:10660629; http://dx.doi.org/10.1074/jbc.275.6.4532
   PubMed Web of Science ®Google Scholar
• Corkery D, Thillainadesan G, Coughlan N, Mohan RD, Isovic M, Tini M, Torchia J. Regulation of the BRCA1 gene by an SRC3/53BP1 complex. BMC Biochem 2011; 12:50-62; PMID:21914189; http://dx.doi.org/10.1186/1471-2091-12-50
   PubMed Web of Science ®Google Scholar
• Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, Tsugane S. Tobacco smoking and breast cancer risk: An evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 2006; 36:387-94; PMID:16766567; http://dx.doi.org/10.1093/jjco/hyl031
   PubMed Web of Science ®Google Scholar
• Dumitrescu RG, Shields PG. The etiology of alcohol-induced breast cancer. Alcohol 2005; 35:213-25; PMID:16054983; http://dx.doi.org/10.1016/j.alcohol.2005.04.005
   PubMed Web of Science ®Google Scholar
• Shrubsole MJ, Gao YT, Dai Q, Shu XO, Ruan ZX, Jin F, Zheng W. Passive smoking and breast cancer risk among non-smoking Chinese women. Int J Cancer 2004; 110:605-9; PMID:15122595; http://dx.doi.org/10.1002/ijc.20168
   PubMed Web of Science ®Google Scholar
• Coyle YM. The effect of environment on breast cancer risk. Breast Cancer Res Treat 2004; 84:273-88; PMID:15026625; http://dx.doi.org/10.1023/B:BREA.0000019964.33963.09
   PubMed Web of Science ®Google Scholar
• Snedeker SM. Chemical exposures in the workplace: effect on breast cancer risk among women. AAOHN J 2006; 54:270-9; PMID:16800404; http://dx.doi.org/10.1177/216507990605400604
   PubMedGoogle Scholar
• Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D, Berlin JA, Daling JR, McDonald JA, Norman SA, et al. Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst 2005; 97:1671-9; PMID:16288120; http://dx.doi.org/10.1093/jnci/dji374
   PubMed Web of Science ®Google Scholar
• Ganmaa D, Willett WC, Li TY, Feskanich D, van Dam RM, Lopez-Garcia E, Hunter DJ, Holmes MD. Coffee, tea, caffeine and risk of breast cancer: A 22-year follow-up. Int J Cancer 2008; 122:2071-6; PMID:18183588; http://dx.doi.org/10.1002/ijc.23336
   PubMed Web of Science ®Google Scholar
• Emery J, Lucassen A, Murphy M. Common hereditary cancers and implications for primary care. Lancet 2001; 358:56-63; http://dx.doi.org/10.1016/S0140-6736(00)05257-0
   PubMed Web of Science ®Google Scholar
• Sunpaweravong S, Sunpaweravong P. Recent developments in critical genes in the molecular biology of breast cancer. Asian J Surg 2005; 28:71-5; PMID:15691805; http://dx.doi.org/10.1016/S1015-9584(09)60265-7
   PubMedGoogle Scholar
• Yarden RI, Papa MZ. BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions. Mol Cancer Ther 2006; 5:1396-404; PMID:16818497; http://dx.doi.org/10.1158/1535-7163.MCT-05-0471
   PubMed Web of Science ®Google Scholar
• Wu W, Koike A, Takeshita T, Ohta T. The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Div 2008; 3:1-10; PMID:18179693; http://dx.doi.org/10.1186/1747-1028-3-1
   PubMed Web of Science ®Google Scholar
• Rosen EM, Fan S, Ma Y. BRCA1 regulation of transcription. Cancer Lett 2006; 236:175-85; PMID:15975711; http://dx.doi.org/10.1016/j.canlet.2005.04.037
   PubMed Web of Science ®Google Scholar
• Deng CX. Roles of BRCA1 in centrosome duplication. Oncogene 2002; 21:6222-7; PMID:12214252; http://dx.doi.org/10.1038/sj.onc.1205713
   PubMed Web of Science ®Google Scholar
• Wang RH, Yu H, Deng CX. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint. Proc Natl Acad Sci USA 2004; 101:17108-13; PMID:15563594; http://dx.doi.org/10.1073/pnas.0407585101
   PubMed Web of Science ®Google Scholar
• Yun MH, Hiom K. Understanding the functions of BRCA1 in the DNA-damage response. Biochem Soc Trans 2009; 37:597-604; PMID:19442256; http://dx.doi.org/10.1042/BST0370597
   PubMed Web of Science ®Google Scholar
• Zhang J, Powell SN. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res 2005; 3:531-9; PMID:16254187; http://dx.doi.org/10.1158/1541-7786.MCR-05-0192
   PubMed Web of Science ®Google Scholar
• Hartman AR, Ford JM. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat Genet 2002; 32:180-4; PMID:12195423; http://dx.doi.org/10.1038/ng953
   PubMed Web of Science ®Google Scholar
• Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol 2001; 155:911-22; PMID:11739404; http://dx.doi.org/10.1083/jcb.200108049
   PubMed Web of Science ®Google Scholar
• Xu B, Kim ST, Kastan MB. Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation. Mol Cell Biol 2001; 21:3445-50; PMID:11313470; http://dx.doi.org/10.1128/MCB.21.10.3445-3450.2001
   PubMed Web of Science ®Google Scholar
• Thangaraju M, Kaufmann SH, Couch FJ. BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J Biol Chem 2000; 275:33487-96; PMID:10938285; http://dx.doi.org/10.1074/jbc.M005824200
   PubMed Web of Science ®Google Scholar
• Parvin JD. Overview of history and progress in BRCA1 research: the first BRCA1 decade. Cancer Biol Ther 2004; 3:505-8; PMID:15197353; http://dx.doi.org/10.4161/cbt.3.6.839
   PubMed Web of Science ®Google Scholar
• Rosen EM, Fan S, Isaacs C. BRCA1 in hormonal carcinogenesis: basic and clinical research. Endocr Relat Cancer 2005; 12:533-48; PMID:16172191; http://dx.doi.org/10.1677/erc.1.00972
   PubMed Web of Science ®Google Scholar
• Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. J Cell Physiol 2003; 196:19-41; PMID:12767038; http://dx.doi.org/10.1002/jcp.10257
   PubMed Web of Science ®Google Scholar
• Taylor J, Lymboura M, Pace PE, A'hern RP, Desai AJ, Shousha S, Coombes RC, Ali S. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int J Cancer 1998; 21:334-42; http://dx.doi.org/10.1002/(SICI)1097-0215(19980821)79:4<334::AID-IJC5>3.0.CO;2-W
   Web of Science ®Google Scholar
• Wilson CA, Ramos L, Villaseñor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 1999; 21:236-40; PMID:9988281; http://dx.doi.org/10.1038/6029
   PubMed Web of Science ®Google Scholar
• Gudas JM, Nguyen H, Li T, Cowan KH. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 1995; 55:4561-5; PMID:7553629.
   PubMed Web of Science ®Google Scholar
• Romagnolo D, Annab LA, Thompson TE, Risinger JI, Terry LA, Barrett JC, Afshari CA. Estrogen upregulation of BRCA1 expression with no effect on localization. Mol Carcinog 1998 Jun; 22(2):102-9; PMID:9655254; http://dx.doi.org/10.1002/(SICI)1098-2744(1998-06)22:2<102::AID-MC5>3.0.CO;2-O
   PubMed Web of Science ®Google Scholar
• Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, et al. p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res 2002; 62:141-51; PMID:11782371
   PubMed Web of Science ®Google Scholar
• Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM, Warrington JA, King MC. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci U S A 2002 May 28; 99(11):7560-5; PMID:12032322; http://dx.doi.org/10.1073/pnas.062181799
   PubMed Web of Science ®Google Scholar
• Yoshida M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 2005; 24:5931-7; PMID:16155600; http://dx.doi.org/10.1038/sj.onc.1208981
   PubMed Web of Science ®Google Scholar
• Grassi MF, Olavarria VN, Kruschewsky RA, Mascarenhas RE, Dourado I, Correia LC, de Castro-Costa CM, Galvao-Castro B. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP. J Med Virol 2011; 83:1269-74; PMID:21567429; http://dx.doi.org/10.1002/jmv.22087
   PubMed Web of Science ®Google Scholar
• Ohshima K. Pathological features of diseases associated with human T-cell leukemia virus type I. Cancer Sci 2007; 98:772-8; PMID:17388788; http://dx.doi.org/10.1111/j.1349-7006.2007.00456.x
   PubMed Web of Science ®Google Scholar
• Azran I, Schavinsky-Khrapunsky Y, Aboud M. Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology 2004; 1:20-43; PMID:15310405; http://dx.doi.org/10.1186/1742-4690-1-20
   PubMedGoogle Scholar
• Azran I, Schavinsky-Khrapunsky Y, Priel E, Huleihel M, Aboud M. Implications of the evolution pattern of human T-cell leukemia retroviruses on their pathogenic virulence. Int J Molec Med 2004; 14:909-15; PMID:15492865.
   PubMed Web of Science ®Google Scholar
• Tabakin-Fix Y, Azran-Shaish I, Levy O, Aboud M. Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: Mechanisms and clinical implications. Carcinogenesis 2006; 27:673-81; PMID:16308315; http://dx.doi.org/10.1093/carcin/bgi274
   PubMed Web of Science ®Google Scholar
• Zhang H, Somasundaram K, Peng Y, Tian H, ZhangH, Bi D, Weber BL, El-Deiry WS. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 1998; 16:1713-21; PMID:9582019; http://dx.doi.org/10.1038/sj.onc.1201932
   PubMed Web of Science ®Google Scholar
• Somasundaram K, MacLachlan TK, Burns TF, Sgagias M, Cowan KH, Weber BL, El-Deiry WS. BRCA1 signals ARF-dependent stabilization and coactivation of p53. Oncogene 1999; 18:6605-14; PMID:10597265; http://dx.doi.org/10.1038/sj.onc.1203284
   PubMed Web of Science ®Google Scholar
• MacLachlan TK, Takimoto R, El-Deiry WS. BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol Cell Biol 2002; 22:4280-92; PMID:12024039; http://dx.doi.org/10.1128/MCB.22.12.4280-4292.2002
   PubMed Web of Science ®Google Scholar
• Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM. CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci USA 2000; 97:1020-5; PMID:10655477; http://dx.doi.org/10.1073/pnas.97.3.1020
   PubMed Web of Science ®Google Scholar
• Yan JP, Garrus JE, Giebler HA, Stargell LA, Nyborg JK. Molecular interactions between the coactivator CBP and the human T-cell leukemia virus Tax protein. J Mol Biol 1998; 281:395-400; PMID:9698555; http://dx.doi.org/10.1006/jmbi.1998.1951
   PubMed Web of Science ®Google Scholar
• Harrod R, Kuo Y, Tang Y, Yao Y, Vassilev A, Nakatani Y, Giam C. p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J Biol Chem 2000; 275:11852-7; PMID:10766811; http://dx.doi.org/10.1074/jbc.275.16.11852
   PubMed Web of Science ®Google Scholar
• Van Orden K, Yan JP, Ulloa A, Nyborg JK. Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control. Oncogene 1999; 18:3766-72; PMID:10391685; http://dx.doi.org/10.1038/sj.onc.1202703
   PubMed Web of Science ®Google Scholar
• Riou P, Bex F, Gazzolo L. The human T cell leukemia/lymphotropic virus Type 1 Tax protein represses MyoD-dependent transcription by inhibiting MyoD-binding to the KIX domain of p300. A potential mechanism for Tax-mediated repression of the transcriptional activity of basic helix-loop-helix factors. J Biol Chem 2000; 275:10551-60; PMID:10744749; http://dx.doi.org/10.1074/bc.275.14.10551
   PubMed Web of Science ®Google Scholar
• Peloponese JM, Yeung ML, Jeang KT. Modulation of nuclear factor-kB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol Res 2006; 34:1-12; PMID:16720895; http://dx.doi.org/10.1385/IR:34:1:1
   PubMed Web of Science ®Google Scholar
• Kawakami A, Nakashima T, Sakai H, Urayama S, Yamasaki S, Hida, A, Tsuboi M, Nakamura H, Ida H, Migita K, Kawabe Y, et al. Inhibition of caspase cascade by HTLV-I Tax through inhibition of NF-kB nuclear translocation. Blood 1999; 94:3847-54; PMID:10572100
   PubMed Web of Science ®Google Scholar
• Pumfery A, de La Fuente C, Kashanchi F. HTLV-1 Tax: Centrosome amplification and cancer. Retrovirology 2006; 3:50; PMID:16899128; http://dx.doi.org/10.1186/1742-4690-3-50
   PubMed Web of Science ®Google Scholar
• Sasaki M, Sugimoto K, Tamayose K, Ando M, Tanaka Y, Oshimi K. Spindle checkpoint protein Bub1 corrects mitotic aberrancy induced by human T-cell leukemia virus type I Tax. Oncogene 2006; 25:3621-7; PMID:16449967; http://dx.doi.org/10.1038/sj.onc.1209404
   PubMed Web of Science ®Google Scholar
• Marriott SJ, Semmes OJ. Impact of HTLV-1 Tax on cell cycle progression and cellular DNA damage repair response. Oncogene 2005; 24:5986-95; PMID:16155605; http://dx.doi.org/10.1038/sj.onc.1208976
   PubMed Web of Science ®Google Scholar
• Shukrun M, Jabareen A, Abou-Kandil A, Chamias R, Aboud M, Huleihel M. HTLV-1 Tax oncoprotein inhibits the estrogen-induced-ER α-Mediated BRCA1 expression by interaction with CBP/p300 cofactors. PLoS One 2014 Feb 21; 9(2):e89390; PMID:24586743; http://dx.doi.org/10.1371/journal.pone.0089390
   PubMedGoogle Scholar
• Lacroix M, Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat Feb 2004; 83:249-89; http://dx.doi.org/10.1023/B:BREA.0000014042.54925.cc
   PubMed Web of Science ®Google Scholar
• Bartek J, Bartkova J, Kyprianou N, Lalani EN, StaskovaZ, Shearer M, Chang S, Taylor-Papadimitriou J. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci U S A 1991; 88:3520-4; PMID:1708884; http://dx.doi.org/10.1073/pnas.88.9.3520
   PubMed Web of Science ®Google Scholar
• Veprik A, Khanin M, Hermoni KL, Danilenko M, Levy Y, Sharoni Y. Polyphenols, isothiocyanates and carotenoid derivatives enhance estrogenic activity in bone cells but inhibit it in breast cancer cells. Am J Physiol Endocrinol Metab 2011 Aug Aug [Epub ahead of print]; PMID:21878663.
   PubMedGoogle Scholar
• Bartholin L, Guindon S, Martel S, Corbo L, Rimokh R. Identification of NF-kB responsive elements in follistatin related gene (FLRG) promoter. Gene Dev 2007; 393:153-62
   Google Scholar
• Smith M, Green W. Identification of HTLV-1 tax transactivator mutants exhibiting novel transcriptional phenotypes. Gene Dev 1990; 4:1875-85; PMID:2276622; http://dx.doi.org/10.1101/gad.4.11.1875
   PubMed Web of Science ®Google Scholar
• Torgeman A, Mor-Vaknin N, Zelin E, Ben-Aroya Z, Lochelt M, Flugel RM, Aboud M. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C. Virology 2001; 281:10-20; PMID:11222091; http://dx.doi.org/10.1006/viro.2000.0779
   PubMed Web of Science ®Google Scholar
• xMor-Vaknin N, Torgeman A, Galron D, Lochelt M, Flugel RM, Aboud M. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways. Virology 1997; 232:337-44; PMID:9191847; http://dx.doi.org/10.1006/viro.1997.8566
   PubMed Web of Science ®Google Scholar
• Demizu Y, Misawa T, Nagakubo T, Kanda Y, Okuhira K, Sekino Y, Naito M, Kurihara M. Structural development of stabilized helical peptides as inhibitors of estrogen receptor (ER)-mediated transcription. Bioorganic Medicinal Chem 2015; 23:4132-8; http://dx.doi.org/10.1016/j.bmc.2015.06.067
   PubMed Web of Science ®Google Scholar
• Hockings JK, Degner SC, Morgan SS, Kemp MQ, Romagnolo DF. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Breast Cancer Resi 2008; 10:R29. Epub 2008 Mar 31; http://dx.doi.org/10.1186/bcr1987
   Google Scholar
• Azran-Shaish I, Tabakin-Fix Y, Huleihel M, Bakhanashvili M, Aboud M. HTLV-1 tax-induced NF-kB activation is synergistically enhanced by 12-O-tetradecanoylphorbol-13-acetate: mechanism and implications for Tax oncogenicity. J Mol Med 2008; 86:799-814; PMID:18425496; http://dx.doi.org/10.1007/s00109-008-0335-1
   PubMed Web of Science ®Google Scholar
• Cho WK, Zhou M, Jang MK, Huang K, Jeong SJ, Ozato K, Brady JN. Modulation of the Brd4/P-TEFb Interaction by the Human T-Lymphotropic Virus Type 1 Tax Protein. J Virol 2007; 81:11179-86; PMID:17686863; http://dx.doi.org/10.1128/JVI.00408-07
   PubMed Web of Science ®Google Scholar
• Yik JH, Chen R, Pezda AC, Zhou Q. Compensatory contributions of HEXIM1 and HEXIM2 in maintaining the balance of active and inactive positive transcription elongation factor b complexes for control of transcription. J Biol Chem 2005 Apr Apr; 280(16):16368-76; PMID:15713661; http://dx.doi.org/10.1074/jbc.M500912200
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhu Q, Luo K, Zhou Q. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 2001; 414:317-22; PMID:11713532; http://dx.doi.org/10.1038/35104575
   PubMed Web of Science ®Google Scholar
• Yang Z, Yik JH, Chen R, He N, Jang MK, Ozato K, Zhou Q. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 2005; 19:535-45; PMID:16109377; http://dx.doi.org/10.1016/j.molcel.2005.06.029
   PubMed Web of Science ®Google Scholar
• Ramirez JA, Nyborg JK. Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300. J Mol Biol 2007; 372:958-69; PMID:17707401; http://dx.doi.org/10.1016/j.jmb.2007.06.062
   PubMed Web of Science ®Google Scholar
• Scoggin KE, Ulloa A, Nyborg JK. The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation. Mol Cell Biol 2001; 21:5520-30; PMID:11463834; http://dx.doi.org/10.1128/MCB.21.16.5520-5530.2001
   PubMed Web of Science ®Google Scholar
• Masiakowski P, Breathnach R, Bloch J, Gannon F, KrustA, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982; 10:7895-903; PMID:6897676; http://dx.doi.org/10.1093/nar/10.24.7895
   PubMed Web of Science ®Google Scholar
• Trevisan R, Daprai L, Paloschi L, Vajente N, Chieco-Bianchi L, Saggioro D. Antiapoptotic effect of human T-cell leukemia virus type 1 tax protein correlates with its creb transcriptional activity. Exp Cell Res 2006; 1390-400; PMID:16483570; http://dx.doi.org/10.1016/j.yexcr.2006.01.009
   PubMed Web of Science ®Google Scholar
• Reid G, Hübner MR, Métivier R, Brand H, DengerS, Manu D, Beaudouin J, Ellenberg J, Gannon F. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 2003; 11:695-707; PMID:12667452; http://dx.doi.org/10.1016/S1097-2765(03)00090-X
   PubMed Web of Science ®Google Scholar
• Mocquet V, Neusiedler J, Rende F, Cluet D, Robin JP, Terme JM, Duc Dodon M, Wittmann J, Morris C, Le Hir H, et al. The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1. J Virol 2012; 86(14):7530-43; PMID:22553336; http://dx.doi.org/10.1128/JVI.07021-11
   PubMed Web of Science ®Google Scholar
• Terme JM, Wencker M, Favre-Bonvin A, Bex F, Gazzolo L, Duc Dodon M, Jalinot P. Cross talk between expression of the human T-cell leukemia virus type 1 Tax transactivator and the oncogenic bHLH transcription factor TAL1. J Virol 2008; 82(16):7913-22; PMID:18495761; http://dx.doi.org/10.1128/JVI.02414-07
   PubMed Web of Science ®Google Scholar
• Cho WK, Jang MK, Huang K, Pise-Masison CA, Brady JN. Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding. J Virol Dec 2010; 84(24):12801-9; doi: 101128/JVI00943-10 Epub Oct 6 2010; http://dx.doi.org/10.1128/JVI.00943-10
   PubMed Web of Science ®Google Scholar
• Zhou M, Lu H, Park H, Wilson-Chiru J, Linton R, Brady JN. Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription. J Virol 2006; 80(10):4781-91; PMID:16641271; http://dx.doi.org/10.1128/JVI.80.10.4781-4791.2006
   PubMed Web of Science ®Google Scholar
• Zhang J, Yamada O, Kawagishi K, Araki H, YamaokaS, Hattori T, Shimotohno K. Human T-cell leukemia virus type 1 Tax modulates interferon-α signal transduction through competitive usage of the coactivator CBP/p300. Virology 2008; 379(2):306-13; PMID:18678383; http://dx.doi.org/10.1016/j.virol.2008.06.035
   PubMed Web of Science ®Google Scholar
• Iwanaga R, Ozono E, Fujisawa J, Ikeda MA, OkamuraN, Huang Y, Ohtani K. Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-I Tax. Oncogene 2008; 27(42):5635-42; PMID:18504428; http://dx.doi.org/10.1038/onc.2008.174
   PubMed Web of Science ®Google Scholar
• Hayashibara T, Yamada Y, Mori N, Harasawa H, SugaharaK, Miyanishi T, Kamihira S, Tomonaga M. Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: constitutive activation of AhR in ATL. Biochem Biophys Res Commun 2003; 300(1):128-34; PMID:12480531; http://dx.doi.org/10.1016/S0006-291X(02)02793-6
   PubMed Web of Science ®Google Scholar
• Goi C, Little P, Xie C. Cell-type and transcription factor specific enrichment of transcriptional cofactor motifs in ENCODE ChIP-seq data. BMC Genomics 2013; 14(Suppl 5):S2; PMID:24564528; http://dx.doi.org/10.1186/1471-2164-14-S5-S2
   PubMedGoogle Scholar
• Liu Z, Merkurjev D, Yang F, Li W, Oh S, Friedman MJ, Song X, Zhang F, Ma Q, Ohgi KA, et al. Enhancer activation requires trans-recruitment of a mega transcription factor complex. Cell 2014; 159(2):358-73; PMID:25303530; http://dx.doi.org/10.1016/j.cell.2014.08.027
   PubMed Web of Science ®Google Scholar
• Colleran A, Collins PE, Carmody RJ. Assessing sites of NF-κB DNA binding using chromatin immunoprecipitation. Methods Mol Biol 2015; 1280:47-59; PMID:25736743; http://dx.doi.org/10.1007/978-1-4939-2422-6_4
   PubMedGoogle Scholar
• Galea GL, Meakin LB, Sugiyama T, Zebda N, SuntersA, Taipaleenmaki H, Stein GS, van Wijnen AJ, Lanyon LE, Price JS. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β. J Biol Chem 2013; 288(13):9035-48; PMID:23362266; http://dx.doi.org/10.1074/jbc.M112.405456
   PubMed Web of Science ®Google Scholar
• Martín M. Molecular biology of breast cancer. Clin Transl Oncol 2006; 8(1):7-14; http://dx.doi.org/10.1007/s12094-006-0089-6
   PubMedGoogle Scholar
• Southern S, Southern P. Cellular mechanism for milk-borne transmission of HIV and HTLV. Adv Exp Med Biol 2002; 503:183-90; PMID:12026019; http://dx.doi.org/10.1007/978-1-4615-0559-4_21
   PubMed Web of Science ®Google Scholar
• LeVasseur RJ, Southern SO, Southern P. Mammary epithelial cells support and transfer productive human T-cell lymphotropic virus infections. J Hum Virol 1998; 1(3):214-23; PMID:10195245
   PubMedGoogle Scholar
• Moreira-Ramos K, Castro FM, Linhares-Lacerda L, Savino W. Can thymic epithelial cells be infected by human T-lymphotropic virus type 1? Mem Inst Oswaldo Cruz 2011; 106(6):759-62; PMID:22012233; http://dx.doi.org/10.1590/S0074-02762011000600018
   PubMed Web of Science ®Google Scholar
• Zhou M, Lu H, Park H, Wilson-Chiru J, Linton R, Brady JN. Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription. J Virol 2006; 80(10):4781-91; PMID:16641271; http://dx.doi.org/10.1128/JVI.80.10.4781-4791.2006
   PubMed Web of Science ®Google Scholar
• Liu B, Li Z, Mahesh SP, Kurup SK, Giam CZ, Nussenblatt RB. HTLV-1 infection of human retinal pigment epithelial cells and inhibition of viral infection by an antibody to ICAM-1. Invest Ophthalmol Vis Sci 2006; 47(4):1510-5; PMID:16565386; http://dx.doi.org/10.1167/iovs.05-1277
   PubMed Web of Science ®Google Scholar
• Jack N, Edwards J, Dhanessar W, Benjamin H, Bartholomew C. A study of HTLV-I infection and breast cancers in Trinidad and Tobago. Int J Cancer 2000; 85(2):298-9; PMID:10629093; http://dx.doi.org/10.1002/(SICI)1097-0215(20000115)85:2<298::AID-IJC24>3.0.CO;2-L
   PubMed Web of Science ®Google Scholar
• Jack N, Edwards J, Dhanessar W, Benjamin H, Bartholomew C. A study of HTLV-I infection and breast cancers in Trinidad and Tobago. Int J Cancer 2000; 85:298-9; PMID:10629093; http://dx.doi.org/10.1002/(SICI)1097-0215(20000115)85:2<298::AID-IJC24>3.0.CO;2-L
   PubMed Web of Science ®Google Scholar
• Arisawa K, Soda M, Akahoshi M, Fujiwara S, UemuraH, Hiyoshi M, Takeda H, Kashino W, Suyama A. Human T-cell lymphotropic virus type-1 infection and risk of cancer: 15.4 year longitudinal study among atomic bomb survivors in Nagasaki, Japan. Cancer Sci 2006; 97(6):535-9; PMID:16734733; http://dx.doi.org/10.1111/j.1349-7006.2006.00212.x
   PubMed Web of Science ®Google Scholar